Showing results (281-290 of 386) with videos related to
Sort By:
Pageof 39
Journal of Clinical Medicine|July 26, 2020
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome DatabaseMev Dominguez-Valentin, Toni T Seppälä, Christoph Engel, et al.Breast Cancer Research and Treatment|June 5, 2008
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyTimothy R Rebbeck, Antonis C Antoniou, Trinidad Caldes Llopis, et al.Gastroenterology|January 12, 2020
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch SyndromeChristoph Engel, Aysel Ahadova, Toni T Seppälä, et al.Journal of Medical Genetics|May 12, 2017
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortiumSetareh Moghadasi, Huong D Meeks, Maaike Pg Vreeswijk, et al.Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.Human Molecular Genetics|April 27, 2010
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersXianshu Wang, V Shane Pankratz, Zachary Fredericksen, et al.Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.Human Mutation|August 18, 2022
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approachMads Thomassen, Romy L S Mesman, Thomas V O Hansen, et al.American Journal of Obstetrics and Gynecology|January 25, 2021
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort studyLieske H Schrijver, Antonis C Antoniou, Håkan Olsson, et al.BMC Public Health|July 23, 2015
The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in GermanyMarkus Loeffler, Christoph Engel, Peter Ahnert, et al.Pageof 39